Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
EXCH
HEM Pharma
★

NDR for Domestic Institutional Investors on May 26-27, 2026

  05/22/2026, 02:42 PM
EXCH
HEM Pharma
★

Microbiome Analysis Service Supply Contract Worth KRW 2.08 Billion with HEM Pharma Japan

  05/14/2026, 01:48 PM
PERI
HEM Pharma
★

HEM Pharma's Q1 2026 Revenue Up but Losses Continue, Debt Ratio Soars to 2,947%

  05/11/2026, 05:50 PM
EXCH
HEM Pharma
★

IR Meeting - Japan MyLab Launch and AI Platform Update

  05/08/2026, 02:28 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.